Bird Global (BRDS) Reports Q2 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Net loss was $ million compared to $ million in the second quarter of 2022
Adjusted EBITDA for the second quarter improved by $27.7 million to $ million from $ million in the second quarter of.
Bird Reports Second Quarter 2023 Financial Results with Improvements in Gross Margin and Operating Expense Spend joplinglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from joplinglobe.com Daily Mail and Mail on Sunday newspapers.
10.05.2023 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will make a cash interest payment of approximately $6.2 million due on June 1, 2023 under its Convertible Senior Secured Notes Indenture. Under the terms of the Indenture, Acorda may . Seite 1
/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it has signed exchange and financing agreements with a fund.